Skip to main content
. 2022 Jun 25;43(9):5289–5300. doi: 10.1007/s10072-022-06168-8

Table 5.

Heterozygous damaging rare variants associated with other autosomal recessive inheritance neurodegenerative disorders

Patient ID Form AOO Sex Symptoms Gene Variant ID Zygosity Clinical significance ACMG classification MAF (non-neuro) Inheritance Patients Controls Reference
P50 F 60 m Short-term memory impairment; parkinsonism, prefrontal symptoms C19ORF12 p.P60A c.178C > G het D LP - AR, AD 1/54 0/137 -
P81 S 59 m Behavioral changes, anxiety PRKN p.T240M c.719C > T rs137853054 het Conf. Of P P  < 0.01 AR 1/54 0/137 [25]
P35 S 61 m Short-term memory impairment, visuospatial disturbancy, dyscalculia, apraxia LRRK2 p.A1862V c.5585C > T het D VUS - AD 1/54 0/137 -
P50 F 60 m Short-term memory impairment, parkinsonism, prefrontal symptoms PARK7 p.Ile91_Leu92fs c.273_274insA het D P - AR 1/54 0/137 -
P35 S 61 m Short-term memory impairment, visuospatial disturbancy, dyscalculia, apraxia SPG11

p. V2053M c.6157G > A

rs149003934

het VUS VUS  < 0.01 AR 1/54 0/137 [24]
P52 F 48 f Depression, memory impairment PSAP p.E108V c.323A > T rs763295469 het D VUS  < 0.01 AR 1/54 0/137 -

From our biobanks, 55 healthy subjects and 82 patients without any neurodegenerative symptoms were selected as controls. F, familial; S, sporadic; AOO, age of onset; f, female; m, male; het., heterozygous; D, damaging; Conf. Of P., conflicting interpretations of pathogenicity; P, pathogenic; LP, likely pathogenic; VUS, variants with uncertain significance; AR, autosomal recessive; AD, autosomal dominant; MAF, minor allele frequency